세계의 연골 수복 시장 규모, 점유율, 동향 분석 보고서 : 치료 모달리티별, 치료법별, 부위별, 용도별, 지역별, 부문별 예측(2025-2030년)

Cartilage Repair Market Size, Share & Trends Analysis Report By Treatment Modalities, By Treatment, By Site (Knee Cartilage Repair, Others), By Application (Hyaline Cartilage, Fibrocartilage), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,158,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,529,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,271,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

세계의 연골 수복 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 연골 수복 시장 규모는 2025-2030년까지 CAGR 5.1%를 기록해 2030년 80억 4,000만 달러에 달할 것으로 예측되고 있습니다.

이 시장은 변형성 관절증(OA) 등 뼈 및 관절장애의 유병률 증가, 노인 증가, 세계 사고·관련 상해 급증 등으로 예측 기간 중에 유리한 성장이 예상되고 있습니다.

세계의 교통사고 증가로 뼈와 관절 손상이 증가하고 있으며 예측 기간 동안 연골 수복 제품 수요가 높아질 것으로 예측됩니다.

미국에서는 매년 약 3,000만 명의 유아와 청년이 청소년 스포츠에 참가하고 있습니다. American Orthopedic Society for Sports Medicine의 조사 데이터에 따르면 매년 350만 명 이상의 선수들이 스포츠 외상 치료를 받고 있습니다.

연골 수복 시장 보고서 하이라이트

• 세포 기반 치료법 부문은 2024년에 60.5% 이상의 최대 시장 점유율을 차지하고 예측 기간 동안 가장 빠른 CAGR을 나타낼 전망입니다.
• 이 성장은 손상된 관절 연골을 수술적으로 치료하기 위한자가 연골 세포 이식에 대한 선호도가 증가하고 있기 때문입니다.
• 내재성 복구 자극 부문은 마이크로 프랙쳐나 드릴링 수술과 같은 신체 자신의 수복 메커니즘을 자극하는 수기에의 기호가 높아지고 있기 때문에 2024년에 가장 높은 시장 수익 점유율을 획득했습니다.
• 무릎 연골 수복 부문은 무릎 연골 손상을 효과적으로 치료하는 고도로 낮은 침습적인 절차에 대한 수요가 증가함에 따라 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예측됩니다.
• 히아린 연골 부문은 연골과 관련된 손상의 경우 손상을 받기 쉽고, 스포츠 부상 증가로 2024년에 큰 시장 수익 점유율을 차지했습니다.
• 북미는 뼈 및 관절장애의 유병률의 상승, 사고 및 부상 증가, 고령자 증가에 의해 2024년 세계 시장을 독점했습니다.
• 미국 국립의료도서관의 기사에 따르면, 미국에서의 의사진단에 의한 관절염의 유병률은 49%로 증가해, 2040년까지 7,840만명(성인 인구의 25.9%)을 차지할 것으로 예측되고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 연골 수복 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/보조시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 연골 수복 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 연골 수복 시장 : 치료 모달리티별, 추정 및 동향 분석

• 치료 모달리티 부문 대시보드
• 연골 수복 시장 : 치료 양식 변동 분석
• 세계의 연골 수복 시장 규모와 동향 분석(치료 모달리티별, 2018-2030년)
• 세포 기반 연골 수복
  • 연골세포 이식 및 ACI
  • 성장인자기술
  • 기타
• 비세포성 연골 수복
  • 조직 스캐폴드
  • 무세포 복합재료
  • 기타

제5장 연골 수복 시장 : 치료법별, 추정 및 동향 분석

• 치료법 부문 대시보드
• 연골 수복 시장 : 치료법 변동 분석
• 연골 수복 시장 규모와 동향 분석(치료법별, 2018-2030년)
• 완화 케어
  • 관절 내 보충 요법
  • 데브리드맨 및 세정
• 내인성 복구 자극

제6장 연골 수복 시장 : 부위별, 추정 및 동향 분석

• 부위 부문 대시보드
• 연골 수복 시장 : 부위 변동 분석
• 연골 수복 시장 규모와 동향 분석(부위별, 2018-2030년)
• 무릎 연골 수복
  • 관절경하 연골성형술
  • 자가 연골 세포
  • 골연골 이식
  • 마이크로 프랙처
  • 기타
• 기타

제7장 연골 수복 시장 : 용도별, 추정 및 동향 분석

• 용도 부문 대시보드
• 연골 수복 시장 : 용도 변동 분석
• 세계의 연골 수복 시장 규모와 동향 분석(용도별, 2018-2030년)
• 유리 연골
• 섬유 연골

제8장 연골 수복 시장 : 지역별, 추정 및 동향 분석

• 지역별 시장 대시보드
• 지역별 시장 점유율 분석, 2024년 및 2030년
• 지역별 연속 바이오프로세스 시장 : 주요 포인트
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제9장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 벤더 상황
  • 주요 기업 히트맵 분석, 2024년
• 기업 프로파일
  • Zimmer Biomet
  • Stryker
  • Collagen Solutions(US) LLC
  • BD(Becton, Dickinson and Company)
  • Arthrex, Inc.
  • Anika Therapeutics, Inc.
  • BE Braun SE
  • Smith Nephew
  • Vericel Corporation
  • Johnson and Johnson Services, Inc.
  • Medacta International

>JHS

영문 목차

영문목차

Cartilage Repair Market Growth & Trends:

The global cartilage repair market size is expected to reach USD 8.04 billion by 2030, registering a CAGR of 5.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth over the forecast period, owing to the increasing prevalence of bone & joint disorders, such as Osteoarthritis (OA), rising geriatric population, and surge in the number of accidents & related injuries across the globe.

An increasing number of road accidents worldwide is causing bone and joint injuries, which is anticipated to fuel the demand for cartilage repair products over the forecast period. According to the WHO, in December 2023, every year, around 20 and 50 million more people suffer non-fatal injuries, resulting in a disability.

Around 30.0 million children and adolescents participate in youth sports in the U.S each year. This increase in sports activity increases incidents of injuries in athletes, which in turn propels the demand for cartilage repair products. According to research data by the American Orthopedic Society for Sports Medicine, over 3.5 million athletes receive medical treatment due to sports injuries each year.

Cartilage Repair Market Report Highlights:

• The cell-based modalities segment held the largest market share of over 60.5% in 2024 and is expected to grow at the fastest CAGR during the forecast period
• This growth can be attributed to the rising preference for autologous chondrocyte transplantation for surgically treating damaged articular cartilage.
• The intrinsic repair stimulus segment commanded highest market revenue share in 2024 due to the growing preference for techniques that stimulate the body's own repair mechanisms, such as microfracture and drilling procedures
• The knee cartilage repair segment is expected to grow at the highest CAGR during the forecast period due to rising demand for advanced and minimally invasive procedures that effectively treat knee cartilage damage
• The hyaline cartilage segment held a significant market revenue share in 2024 due to its high susceptibility to damage in case of cartilage-related injuries and an increase in sports injuries.
• North America dominated the global market in 2024, owing to the rising prevalence of bone & joint disorders, an increase in the number of accidents & injuries, and a growing geriatric population.
• According to an article in the National Library of Medicine, the prevalence of doctor-diagnosed arthritis in the U.S. is projected to increase to 49%, accounting for 78.4 million people (25.9% of the adult population) by 2040

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Treatment Modality
  • 1.2.2. Treatment
  • 1.2.3. Site
  • 1.2.4. Application
  • 1.2.5. Regional Scope
  • 1.2.6. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Treatment Modality
  • 2.2.2. Treatment
  • 2.2.3. Site
  • 2.2.4. Application
  • 2.2.5. Regional
• 2.3. Competitive Insights

Chapter 3. Cartilage Repair Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Cartilage Repair Market Analysis tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Cartilage Repair Market: Treatment Modality Estimates & Trend Analysis

• 4.1. Treatment Modality Segment Dashboard
• 4.2. Cartilage Repair Market: Treatment Modality Movement Analysis
• 4.3. Global Cartilage Repair Market Size & Trend Analysis, by Treatment Modality, 2018 to 2030 (USD Million)
• 4.4. Cell based Cartilage Repair
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Chondrocyte Transplantation/ACI
    • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Growth Factor Technology
    • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Non-cell based Cartilage Repair
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Tissue Scaffolds
    • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Cell Free Composites
    • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Cartilage Repair Market: Treatment Estimates & Trend Analysis

• 5.1. Treatment Segment Dashboard
• 5.2. Cartilage Repair Market: Treatment Movement Analysis
• 5.3. Global Cartilage Repair Market Size & Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
• 5.4. Palliative
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Viscosupplementation
    • 5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Debridement & Lavage
    • 5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Intrinsic Repair Stimulus

Chapter 6. Cartilage Repair Market: Site Estimates & Trend Analysis

• 6.1. Site Segment Dashboard
• 6.2. Cartilage Repair Market: Site Movement Analysis
• 6.3. Global Cartilage Repair Market Size & Trend Analysis, by Site, 2018 to 2030 (USD Million)
• 6.4. Knee Cartilage Repair
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Arthroscopic Chondroplasty
    • 6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Autologous Chondrocyte
    • 6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Osteochondral Grafts Transplantation
    • 6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Microfracture
    • 6.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Others
    • 6.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Cartilage Repair Market: Application Estimates & Trend Analysis

• 7.1. Application Segment Dashboard
• 7.2. Cartilage Repair Market: Application Movement Analysis
• 7.3. Global Cartilage Repair Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Hyaline Cartilage
  • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.5. Fibrocartilage
  • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Cartilage Repair Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2024 & 2030
• 8.3. Continuous Bioprocessing Market By Region: Key Takeaways
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key Country Dynamics
    • 8.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.1.3. Competitive Scenario
    • 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Canada
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Mexico
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. UK
    • 8.5.1.1. Key Country Dynamics
    • 8.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.1.3. Competitive Scenario
    • 8.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Germany
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.3. France
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Italy
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Spain
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.5.3. Competitive Scenario
    • 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Denmark
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.6.3. Competitive Scenario
    • 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.7.3. Competitive Scenario
    • 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Norway
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.8.3. Competitive Scenario
    • 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key Country Dynamics
    • 8.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.1.3. Competitive Scenario
    • 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.3. India
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Australia
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Thailand
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.6.3. Competitive Scenario
    • 8.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Brazil
    • 8.7.1.1. Key Country Dynamics
    • 8.7.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.7.1.3. Competitive Scenario
    • 8.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Argentina
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.7.2.3. Competitive Scenario
    • 8.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. South Africa
    • 8.8.1.1. Key Country Dynamics
    • 8.8.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.1.3. Competitive Scenario
    • 8.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.2.3. Competitive Scenario
    • 8.8.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.3. UAE
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.3.3. Competitive Scenario
    • 8.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.4. Kuwait
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.4.3. Competitive Scenario
    • 8.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. Key Company Heat Map Analysis, 2024
• 9.4. Company Profiles
  • 9.4.1. Zimmer Biomet
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Stryker
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Collagen Solutions (US) LLC
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. BD (Becton, Dickinson and Company)
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Arthrex, Inc.
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Anika Therapeutics, Inc.
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. BE Braun SE
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Smith+Nephew
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Vericel Corporation
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Johnson and Johnson Services, Inc.
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives
  • 9.4.11. Medacta International
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Financial Performance
    • 9.4.11.3. Product Benchmarking
    • 9.4.11.4. Strategic Initiatives

관련자료